OncoGxOne™ is a comprehensive Next Generation Sequencing (NGS) based test that profiles tumors for targeted therapy selection and chemotherapeutic tolerance.
- 64 gene panel: 56 cancer related genes and 8 genes related to pharmacogenomics.
- Comprehensive coverage of clinically actionable alterations found in multiple cancer types, covering all exons, 5’ and 3’ UTRs, and select introns known to harbor breakpoints.
- Detects SNV, indel, CNV and gene fusion
Pharmacogenomics Related Genes